Phenomenological and Psychopathological Factors Associated to Hallucinations in Parkinson's Disease (HALLUPARK)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03105401|
Recruitment Status : Recruiting
First Posted : April 10, 2017
Last Update Posted : February 19, 2018
This study aims to describe hallucinations prevalence in a sample of patients affected by Parkinson's disease and consulting in an outpatient facility.
An unique one hour interview will be offered to volunteers patients. Patients participating to the study will be asked to answer a semi-structured questionnaire searching for hallucinations of all modalities, minor psychotic symptoms and delusions. Psychometric scales will be assessed to search for depressive symptoms, cognitive impairment and specific personality characteristics.
The study hypothesis is that hallucinations prevalence in Parkinson's disease is underestimated and is higher than usually described in the scientific literature when all hallucinations modalities and minor hallucinatory phenomenons are searched for.
|Condition or disease||Intervention/treatment|
|Parkinson Disease||Other: Assessment of hallucinations in Parkinson's disease|
|Study Type :||Observational|
|Estimated Enrollment :||80 participants|
|Official Title:||Phenomenological and Psychopathological Factors Associated to Hallucinations in Parkinson's Disease|
|Actual Study Start Date :||May 15, 2017|
|Estimated Primary Completion Date :||January 15, 2019|
|Estimated Study Completion Date :||January 15, 2019|
Patients affected by Parkinson's disease
Outpatients affected by Parkinson's Disease consulting in neurology can be included if volunteer
Other: Assessment of hallucinations in Parkinson's disease
Patients participating to the study will be asked to answer a semi-structured questionnaire searching for hallucinations of all modalities, minor psychotic symptoms and delusions. Psychometric scales will be assessed to search for depressive symptoms, cognitive impairment and specific personality characteristics.
- Hallucinations Prevalence [ Time Frame: 1 hour ]
Semi-structured questionnaire precisely describing hallucinations of all modalities and their characteristics, as well as minor hallucinations and delusions. Binary Yes/No possible answers.
Unique 1 hour interview to assess semi-structured questionnaire for primary outcome measurement, and psychometric scales.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03105401
|Contact: Jing XIE, MD||04 72 43 20 54 ext +email@example.com|
|Contact: Claire MOUTET||04 72 43 22 50 ext +firstname.lastname@example.org|
|Hôpital des Charpennes. Centre de Recherche Clinique - vieillissement, cerveau, fragilité||Recruiting|
|Villeurbanne, France, 69100|
|Contact: Jing XIE, MD 04 72 43 20 54 ext +33 email@example.com|
|Contact: Claire MOUTET 04 72 43 22 50 ext +33 firstname.lastname@example.org|
|Principal Investigator: Jing XIE, MD|
|Sub-Investigator: Mathilde BONZE, MD|
|Principal Investigator:||Jing XIE, MD||Hôpital des Charpennes. Centre de Recherche Clinique - vieillissement, cerveau, fragilité|